GeneDx (WGS) Fell Despite Continued Execution Improvement

3 days ago 5

Soumya Eswaran

Thu, May 14, 2026 astatine 8:13 AM CDT 3 min read

Polen Capital, an concern absorption company, released its first-quarter 2025 capitalist missive for “Polen 5Perspectives Small Growth Strategy”. A transcript of the missive is disposable to download here. Polen 5Perspectives Small Growth Composite Portfolio returned 3.3% gross and 3.0% nett of fees, respectively, successful the archetypal 4th of 2026, compared to the -2.8% instrumentality of the Russell 2000 Growth Index. Small caps performed powerfully astatine the commencement of the archetypal quarter, but marketplace volatility caused a displacement successful focus. Initially, fears of AI disruption successful bundle dominated, followed by worries implicit backstage recognition redemptions raising broader systemic hazard concerns. By March, concerns shifted chiefly to expanding geopolitical risks and their interaction connected rates and inflation. This heightened volatility is expected to proceed for the foreseeable future. The value of adopting a flexible attack to opportunities has go wide this year. In addition, delight cheque the Strategy’s apical 5 holdings to cognize its champion picks successful 2026.

In its first-quarter 2026 capitalist letter, Polen 5Perspectives Small Growth Strategy highlighted GeneDx Holdings Corp. (NASDAQ:WGS). GeneDx Holdings Corp. (NASDAQ:WGS) is simply a genomics institution specializing successful pediatric and uncommon illness diagnostics. On May 13, 2026, GeneDx Holdings Corp. (NASDAQ:WGS) closed astatine $38.94 per share. One-month instrumentality of GeneDx Holdings Corp. (NASDAQ:WGS) was -40.48%, and its shares mislaid 38.78% implicit the past 52 weeks. GeneDx Holdings Corp. (NASDAQ:WGS) has a marketplace capitalization of $1.16 billion.

Polen 5Perspectives Small Growth Strategy stated the pursuing regarding GeneDx Holdings Corp. (NASDAQ:WGS) successful its Q1 2026 capitalist letter:

"GeneDx Holdings Corp. (NASDAQ:WGS) is simply a supplier of genomic investigating and diagnostics, utilizing precocious sequencing exertion to assistance clinicians diagnose uncommon diseases and pass attraction decisions. After much than doubling successful the backmost fractional of 2025, shares underperformed during the 4th arsenic investors digested gains and near-term expectations reset. While the institution continues to study coagulated gross maturation and improving profitability, immoderate variability successful investigating volumes and reimbursement dynamics created humble uncertainty. Additionally, broader volatility crossed high-growth healthcare names weighed connected sentiment contempt continued advancement successful execution."

Is Personalis, Inc. (PSNL) the Best Multibagger Penny Stock to Buy According to Billionaires?

GeneDx Holdings Corp. (NASDAQ:WGS) is not connected our database of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 39 hedge money portfolios held GeneDx Holdings Corp. (NASDAQ:WGS) astatine the extremity of the 4th quarter, up from 34 successful the erstwhile quarter. In Q1 2026, GeneDx Holdings Corp.'s (NASDAQ:WGS) full gross came successful $12 cardinal little than anticipated, contempt stronger than expected measurement growth. While we admit the imaginable of GeneDx Holdings Corp. (NASDAQ:WGS) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

Read Entire Article